Turn back time: oncology trials are getting shorter
This article was originally published in Scrip
Executive Summary
It is widely accepted in the biopharmaceutical industry that clinical trial protocols are growing in complexity; many in the business bewail that the duration of trials is increasing, with patient enrollment a frequently-cited problem in clinical development.